# Urinary Biomarkers for AKI Diagnosis in Patients With SARS-CoV-2 (COVID-19)

> **NCT04393428** · — · COMPLETED · sponsor: **University Hospital, Montpellier** · enrollment: 100 (actual)

## Conditions studied

- COVID-19
- Renal Replacement Therapy
- Acute Kidney Injury

## Interventions

- **OTHER:** [TIMP-2]*[IGFBP-7]

## Key facts

- **NCT ID:** NCT04393428
- **Lead sponsor:** University Hospital, Montpellier
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-03-01
- **Primary completion:** 2020-06-01
- **Final completion:** 2020-06-30
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2020-07-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04393428

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04393428, "Urinary Biomarkers for AKI Diagnosis in Patients With SARS-CoV-2 (COVID-19)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04393428. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*